Literature DB >> 7714224

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

C Salzman1, A N Wolfson, A Schatzberg, J Looper, R Henke, M Albanese, J Schwartz, E Miyawaki.   

Abstract

Clinical data and uncontrolled observations have suggested that fluoxetine is helpful in some patients with borderline personality disorder. This article describes the results of a 13-week double-blind study of volunteer subjects with mild to moderately severe borderline personality disorder. Thirteen fluoxetine recipients and nine placebo recipients received treatment. Pretreatment and posttreatment measures were obtained for global mood and functioning, anger, and depression. The most striking finding from this study was a clinically and statistically significant decrease in anger among the fluoxetine recipients. This decrease was independent of changes in depression. These data support previous observations that fluoxetine may reduce anger in patients with borderline personality disorder. The number of subjects in this study was small, the placebo responsiveness was high, and the clinical characteristics of the patients were in the mild to moderate range of severity. The data cannot be extrapolated to more severely ill borderline patients, but further study of fluoxetine and other selective serotonin reuptake inhibitors is indicated in this population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714224     DOI: 10.1097/00004714-199502000-00005

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  31 in total

Review 1.  Update on pharmacotherapy of borderline personality disorder.

Authors:  Mary C Zanarini
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

Review 2.  Psychopharmacology of borderline personality disorder.

Authors:  Y Pritham Raj
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

3.  Self-mutilation and pharmacotherapy.

Authors:  Brian Daniel Smith
Journal:  Psychiatry (Edgmont)       Date:  2005-10

Review 4.  Neuropsychiatry of aggression.

Authors:  Scott D Lane; Kimberly L Kjome; F Gerard Moeller
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

Review 5.  Borderline personality disorder.

Authors:  Joel Paris
Journal:  CMAJ       Date:  2005-06-07       Impact factor: 8.262

Review 6.  Possible role of more positive social behaviour in the clinical effect of antidepressant drugs.

Authors:  Simon N Young; Debbie S Moskowitz; Marije aan het Rot
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

7.  Randomized Controlled Trial of Web-Based Psychoeducation for Women With Borderline Personality Disorder.

Authors:  Mary C Zanarini; Lindsey C Conkey; Christina M Temes; Garrett M Fitzmaurice
Journal:  J Clin Psychiatry       Date:  2018 May/Jun       Impact factor: 4.384

8.  Citalopram intervention for hostility: results of a randomized clinical trial.

Authors:  Thomas W Kamarck; Roger F Haskett; Matthew Muldoon; Janine D Flory; Barbara Anderson; Robert Bies; Bruce Pollock; Stephen B Manuck
Journal:  J Consult Clin Psychol       Date:  2009-02

9.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

10.  Controversies surrounding classification of personality disorder.

Authors:  Youl-Ri Kim; Peter Tyrer
Journal:  Psychiatry Investig       Date:  2010-02-08       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.